Abstract
Summary
REPORT HIGHLIGHT
3D Bioprinting Market was valued at USD 898.9 million by 2018, growing with 17.2% CAGR during the forecast period, 2019-2028.
Market Dynamics
3D bioprinting is a method to induce cells, growth factors and other biotechnology practices in a way that mimics real tissue traits and functionality. In essence, 3D bioprinting works using the same principle of digital 3D printing. Material like Bioink is used to create a layer by layer structure of the cell or material that needs to be modeled. Article published in News Medical Life Sciences website, (Nov 2019), stated that researchers in the Rensselaer Polytechnic Institute have found a way to print living skin with blood vessels. The implications of such a ground-breaking discover can profound.
3D bioprinting is used extensively in research and development procedures. There is a marked increase in healthcare procedures globally. Based on data published in the American Medical Association (March 2019), health care spending costs in the US saw a rise to 3.9%. Factors such as a rise in chronic illnesses, spike in donor requirement and improvement in technological advancements are reasons that boost the demand for 3D bioprinting technology is only about to witness significant growth. All in all, the increase in the general aging population furthers the cause of this 3D bioprinting technology.
Technology Takeaway
Based on technology, the segmentation for the 3D bioprinting market can be classified into magnetic levitation, laser-based, inkjet-based, and syringe-based. Due to a constant rise in the research and development in biotechnology, the syringe category dominates the market. This segment holds the largest market share, however, in terms of the fastest-growing segment the magnetic levitation segment promises untapped potential. Based on data published on the NASA website, (March 2019), magnetic levitation will present scope for “Formative” bio fabrication using 3D bioprinting.
Several biotechnological advances such as muscle printing, human cell regeneration, and toxicity screening are all end-use categories where 3D bioprinting is applicable. Using 3D printing, the rate of failures is due to organ rejection by the recipient may go down significantly. Better precision as a result of 3D bioprinting leads to much more accurate results.
Application Takeaway
The 3D bioprinting market is divided into the following application-wise into medical, dental, biosensors, and bio-inks. Within the medical segment, the market is divided into organ penetration, implants and prosthetics, and medical pills. An article on Genengnews.com (September 2019) states, 3D modeling of complex vascular systems is possible using highly compatible bioinks and can be used for the treatment of vascular illnesses, which account for 17 million deaths per year.
Medical pills are also expected to witness a faster growth pace in the forecasted period. The need for effective medications that are more cost-effective and potent will lead to a rise in this segment. The drug Spritam that is produced by 3D printing is the first of its kind that is known to be beneficial for epileptic patients has been received by the USFDA for approval.
Regional Takeaway
North America is the key player in this category. It dominates the market and is expected to grow consistently over the forecasted period. Some of the other reasons that will speed up the growth trajectory of this 3 D bioprinting market is the high disposable income in this category along with better healthcare infrastructure gives better room for the developing and thriving of this market.
China is also an upcoming market in the 3D bioprinting segment. An article in the Economic Times, (Sept 2019) stated that the University of Wollongong (UOW) has collaborated with Andhra Pradesh Medtech Zone (APMZ) to get in the bioprinting expertise in India. Initiatives such as these will only escalate the industry potential further.
Key Vendor Takeaway
Some of the key players in this segment include Organovo Holding, Cyfuse Biomedical K.K Inc.; TeVido BioDevices LLC; Luxexcel Group B.V.; Aspect Biosystems Ltd.; Stratasys Ltd.; Voxeljet A.G.; Bio3D Technologies Pte. Ltd.; 3Dynamics Systems Ltd.; Materialise N.V.; Solidscape, Inc. (acquired by Prodways Group) and Envision TEC.
The company Organovo has partnered with L’oreal for research and development purposes for research in skin tissue development. Another article published on News Medical net website stated that Regemat3D and Biogelx have announced that they would be collaborating and carrying out distribution activities for offering complete bioprinting solutions.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year – 2017 – 2021
Base Year – 2018
Estimated Year – 2019
Projected Year – 2028
TARGET AUDIENCE
Traders, Distributors, and Suppliers
Manufacturers
Government and Regional Agencies
Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
KEY PLAYERS
Organovo Holding Inc.
Cyfuse Biomedical
BioBots
Luxexcel Group BV
TeVido BioDevices
Aspect Biosystems
3Dynamics Systems
Stratasys Ltd.
Voxeljet
Oceanz
Materialise NV
Envision TEC
Bio3D Technologies
Solidscape
MARKET, BY TECHNOLOGY
Magnetic Levitation
Inkjet based 3D bioprinting
Laser based 3D bioprinting
Syringe based 3D bioprinting
Others
MARKET, BY APPLICATION
Medical
Biosensors
Dental
Bioinks
Consumer/Personal product testing
Food and animal product
Others
MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Singapore
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East and Africa
Saudi Arabia
United Arab Emirates
Rest of MEA
Table of Contents
1 3D BIOPRINTING MARKET OVERVIEW
1.1 Study Scope
1.2 Assumption and Methodology
2 EXECUTIVE SUMMARY
2.1 Market Snippet
2.1.1 Market Snippet by Technology
2.1.2 Market Snippet by Application
2.1.3 Market Snippet by Region
2.2 Competitive Insights
3 3D BIOPRINTING KEY MARKET TRENDS
3.1 Market Drivers
3.1.1 Impact Analysis of Market Drivers
3.2 Market Restraints
3.2.1 Impact Analysis of Market Restraints
3.3 Market Opportunities
3.4 Market Future Trends
4 3D BIOPRINTING INDUSTRY STUDY
4.1 Porter’s Five Forces Analysis
4.2 Marketing Strategy Analysis
4.3 Growth Prospect Mapping
4.4 Regulatory Framework Analysis
5 3D BIOPRINTING MARKET LANDSCAPE
5.1 Market Share Analysis
5.2 Key Innovators
5.3 Breakdown Data, by Key manufacturer
5.3.1 Established Player Analysis
5.3.2 Emerging Player Analysis
6 3D BIOPRINTING MARKET - BY TECHNOLOGY
6.1 Overview
6.1.1 Segment Share Analysis, By Technology, 2018 & 2028 (%)
6.2 Magnetic Levitation
6.2.1 Overview
6.2.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
6.3 Inkjet based 3D Bioprinting
6.3.1 Overview
6.3.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
6.4 Laser based 3D Bioprinting
6.4.1 Overview
6.4.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
6.5 Syringe based 3D Bioprinting
6.5.1 Overview
6.5.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
7 3D BIOPRINTING MARKET - BY APPLICATION
7.1 Overview
7.1.1 Segment Share Analysis, By Application, 2018 & 2028 (%)
7.2 Medical
7.2.1 Overview
7.2.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
7.3 Biosensors
7.3.1 Overview
7.3.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
7.4 Dental
7.4.1 Overview
7.4.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
7.5 Bioinks
7.5.1 Overview
7.5.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
7.6 Consumer/Personal product testing
7.6.1 Overview
7.6.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
7.7 Food and animal product
7.7.1 Overview
7.7.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8 3D BIOPRINTING MARKET- BY GEOGRAPHY
8.1 Introduction
8.1.1 Segment Share Analysis, By Region, 2018 & 2028 (%)
8.2 North America
8.2.1 Overview
8.2.2 Key Manufacturers in North America
8.2.3 North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
8.2.4 North America Market Size and Forecast, By Technology, 2017 - 2028 (US$ Million)
8.2.5 North America Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
8.2.6 U.S
- 8.2.6.1 Overview
- 8.2.6.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.2.7 Canada
- 8.2.7.1 Overview
- 8.2.7.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.3 Europe
8.3.1 Overview
8.3.2 Key Manufacturers in Europe
8.3.3 Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
8.3.4 Europe Market Size and Forecast, By Technology, 2017 - 2028 (US$ Million)
8.3.5 Europe Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
8.3.6 Germany
- 8.3.6.1 Overview
- 8.3.6.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.3.7 Italy
- 8.3.7.1 Overview
- 8.3.7.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.3.8 United Kingdom
- 8.3.8.1 Overview
- 8.3.8.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.3.9 France
- 8.3.9.1 Overview
- 8.3.9.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.3.10 Rest of Europe
- 8.3.10.1 Overview
- 8.3.10.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.4 Asia Pacific (APAC)
8.4.1 Overview
8.4.2 Key Manufacturers in Asia Pacific
8.4.3 Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
8.4.4 Asia Pacific Market Size and Forecast, By Technology, 2017 - 2028 (US$ Million)
8.4.5 Asia Pacific Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
8.4.6 India
- 8.4.6.1 Overview
- 8.4.6.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.4.7 China
- 8.4.7.1 Overview
- 8.4.7.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.4.8 Japan
- 8.4.8.1 Overview
- 8.4.8.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.4.9 South Korea
- 8.4.9.1 Overview
- 8.4.9.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.4.10 Rest of APAC
- 8.4.10.1 Overview
- 8.4.10.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.5 Latin America
8.5.1 Overview
8.5.2 Key Manufacturers in Latin America
8.5.3 Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
8.5.4 Latin America Market Size and Forecast, By Technology, 2017 - 2028 (US$ Million)
8.5.5 Latin America Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
8.5.6 Brazil
- 8.5.6.1 Overview
- 8.5.6.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.5.7 Mexico
- 8.5.7.1 Overview
- 8.5.7.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.5.8 Argentina
- 8.5.8.1 Overview
- 8.5.8.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.5.9 Rest of LATAM
- 8.5.9.1 Overview
- 8.5.9.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.6 Middle East and Africa
8.6.1 Overview
8.6.2 Key Manufacturers in Middle East and Africa
8.6.3 Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
8.6.4 Middle East and Africa Market Size and Forecast, By Technology, 2017 - 2028 (US$ Million)
8.6.5 Middle East and Africa Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
8.6.6 Saudi Arabia
- 8.6.6.1 Overview
- 8.6.6.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
8.6.7 United Arab Emirates
- 8.6.7.1 Overview
- 8.6.7.2 Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9 KEY VENDOR ANALYSIS
9.1 Organovo Holding Inc
9.1.1 Company Snapshot
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Cyfuse Biomedical
9.3 BioBots
9.4 Luxexcel Group BV
9.5 TeVido BioDevices
9.6 Aspect Biosystems
9.7 3Dynamics Systems
9.8 Stratasys Ltd
9.9 Voxeljet
9.10 Oceanz
9.11 Materialise NV
9.12 Envision TEC
9.13 Bio3D Technologies
9.14 Solidscape
11 APPENDIX
11.1 Research Methodology
11.2 References
11.3 Abbreviations
11.4 Disclaimer
11.5 Contact Us